Common Contracts
2 similar Exchange Agreement contracts by AEON Biopharma, Inc.
AMENDMENT NO. 1 to CONVERTIBLE PROMISSORY NOTE Issued by AEON BIOPHARMA, INC., a Delaware corporation And EXCHANGE AGREEMENTExchange Agreement • September 17th, 2021 • AEON Biopharma, Inc. • Pharmaceutical preparations
This Amendment No. 1 (the “Amendment”) and Exchange Agreement in relation to the Convertible Promissory Note (“Note”) issued by AEON Biopharma, Inc., a Delaware corporation (the “Issuer”), to the undersigned holder of the Note (the “Noteholder”) is made and entered into as of September 30, 2020 (the “Effective Date”), between the Issuer and the Noteholder. Capitalized words used herein but not defined herein have the respective meanings ascribed to them in the Note.
AMENDMENT NO. 1 to CONVERTIBLE PROMISSORY NOTE Issued by AEON BIOPHARMA, INC., a Delaware corporation And EXCHANGE AGREEMENTExchange Agreement • September 14th, 2021 • AEON Biopharma, Inc. • Pharmaceutical preparations
This Amendment No. 1 (the “Amendment”) and Exchange Agreement in relation to the Convertible Promissory Note (“Note”) issued by AEON Biopharma, Inc., a Delaware corporation (the “Issuer”), to the undersigned holder of the Note (the “Noteholder”) is made and entered into as of September 30, 2020 (the “Effective Date”), between the Issuer and the Noteholder. Capitalized words used herein but not defined herein have the respective meanings ascribed to them in the Note.
